The Oncology Institute, Inc. (TOI) Misses Q3 EPS by 11c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.18), $0.11 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $99.9 million versus the consensus estimate of $107.54 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• U.S. judge won't block Trump's UFC mixed martial arts event at White House on June 14
• Iran deal reopens Strait of Hormuz - Reuters